STUDIO

BioInvent and CASI on their collaboration

In a BioStock Studio exclusive, Martin Welschof, CEO of BioInvent and Wei-Wu He, Chairman and CEO of the American biopharma company CASI Pharmaceuticals, joined...

RECOMMENDED READING

Idogen

Norwegian doctors prepare for Idogen’s study

Biotech company Idogen is in full swing with preparations for the first clinical study...
Stayble

Stayble’s pathway to phase III and market  

Stayble Therapeutics is in phase IIb with the drug candidate STA363 for the treatment...

EVENT